In summary, TRIM47 plays a post-translational modification role in RCC by exerting an E3 ligase activity, mediating ubiquitination and degradation of P53 tumor suppressor protein and promoting malignant progression of RCC cells at the protein level. Here, TP53 is linked to renal cell carcinoma.